Anti-infective Peptides Market to Benefit from Elevated Research Initiatives from Key Companies

The global anti-infective peptides market is driven by the increasing resistance of pathogens to drugs currently available in the market. The overuse of antifungal, antibacterial, and antiviral drugs has led to a high level of drug resistance in several key pathogen groups. This has led firms in the global peptides market to seek innovative products that will overcome this key challenge.

Innovation from Key Players to Drive Global Anti-infective Peptides Market

Peptides are extensively used in biotechnology and medicine. They act as an endocrine signal or a neurotransmitter for regulation of most physiological processes. Peptides are being examined as having the potential to treat several medical conditions such as diabetes. At present, there are 60 peptide drugs approved by the U.S. Food and Drug Administration (FDA). Furthermore, the use of peptides to treat various infections is currently rising and several key players in the market are involved in these initiatives.

Browse Report: http://www.transparencymarketresearch.com/anti-infective-peptides-market.html

Some of the key players part of anti-infective peptides research and development projects are Actavis, Theravance Biopharma, Adamis Pharmaceuticals, ANI Pharmaceuticals, AstraZeneca, Nanotides Pharmaceuticals, Dipexium Pharmaceuticals, Immunotech Laboratories, Novartis International, and Pfizer. Innovation from these major companies will drive the global anti-infective peptides market in the coming few years.

North America to Dominate Global Market for Anti-infective Peptides

On the basis of geography, the global anti-infective peptides market is segmented into North America, Asia Pacific, Europe, and Rest of the World (RoW). Currently, North America is leading the global anti-infective peptides market, trailed by Europe. The North America anti-infective peptides market benefits from factors such as the sophisticated healthcare infrastructure in countries in the region, rising government funding for research activities, increasing availability of research and development facilities, and a well-structured and favorable regulatory framework. Moreover, the presence of several key companies involved in development of anti-peptides in this region will also support its growth in the foreseeable future.

On the other hand, the Asia Pacific anti-infective peptides market is projected to grow at the highest rate of all geographical segments in the coming few years. The Asia Pacific anti-infective peptides market is driven by the rapidly improving healthcare infrastructure in the region and growing government initiatives to boost the domestic biotechnology sector.

Growing Number of Biological Agents under Development to Fuel Global Market

By type, the global anti-infective peptides market is segmented into anti-viral peptides, anti-bacterial peptides, anti-fungal peptides, anti-HIV peptides, anti-parasitic peptides, anti-microbial peptides, and others. According to the National Center for Biotechnology Information (NCBI), the vast majority of anti-infective therapeutics in development are small molecules. However, this scenario is changing, and there is presently a nascent pipeline of biological agents undergoing development. In the past few years, phage display technologies were deployed to create monoclonal antibodies targeted against inflammatory or cancer disease targets. Furthermore, patent disputes impeded the broad use of this technology and contributed to the dearth of candidates during the 1990s.

However, phase display technology is now recognized as a powerful tool for choosing novel peptides and antibodies capable of binding to a wide range of antigens from whole cells to proteins and lipid targets. This technology to discover novel therapeutics for infectious conditions will further boost the global anti-infective peptides market. Furthermore, improvement in manufacturing, screening, and humanization methods will in turn make a significant contribution to the development of peptides.

Sample Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6257

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contacts

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/